Wearables Reprice Exercise: Vigorous, Moderate, and Light

One minute of vigorous exercise may buy far more health benefit than two minutes of moderate exercise. That is the practical implication of a large UK Biobank analysis using wrist accelerometers: for all-cause mortality, one minute of vigorous physical activity (VPA) corresponded to 4.1 minutes of moderate physical activity (MPA), not the familiar 2:1 guideline convention.

The finding does not mean every hard interval adds years to your life, or that a smartwatch can settle exercise science. It does mean the usual conversion rate between vigorous and moderate activity was not built from direct device-based calibration. Wearable data now offer a more detailed, though still observational, view of what people actually do all day.

Vigorous activity appears more time-efficient than the standard conversion

In a 2025 UK Biobank cohort study by Biswas et al., 73,485 participants wore dominant-wrist accelerometers, and researchers used a machine-learning classifier to sort movement into intensity bands. During an average 8.0 years of follow-up, 2,675 participants died from any cause, 545 died from cardiovascular disease, 2,359 experienced major adverse cardiovascular events, and 1,836 developed type 2 diabetes.

The researchers estimated outcome-specific exchange rates between VPA and MPA. For all-cause mortality, one minute of VPA corresponded to 4.1 minutes of MPA (95% CI, 4.1 to 4.2). The estimate was 7.8 minutes for cardiovascular mortality (95% CI, 7.7 to 8.0), 5.4 minutes for major adverse cardiovascular events (95% CI, 5.3 to 5.5), and 9.3 minutes for type 2 diabetes (95% CI, 9.3 to 9.6).

Those are associations, not a prescription to replace every walk with hill sprints. People who tolerate and choose vigorous activity may differ from people who do not in ways statistical adjustment cannot fully erase. Still, the precision of the estimates and the size of the cohort make the central point hard to ignore: the conventional 1:2 VPA-to-MPA conversion is likely too conservative for several major outcomes.

MPA still mattered. Its risk gradients were steep at lower doses and flattened around 30 minutes per day in this analysis. VPA had nearly linear associations with lower risk across all-cause mortality, cardiovascular mortality, cardiovascular events, and type 2 diabetes. If time is scarce and your health permits vigorous training, intensity appears to have a large return per minute.

Light activity has a signal, but its independent value remains disputed

Light physical activity (LPA) includes slow walking, standing, and gentle household movement. It is the category traditional questionnaires measure badly because they struggle to separate incidental movement from sitting. That matters because much of daily behavior lives in this blurry middle ground, not in a neat 45-minute workout block.

A 2022 meta-analysis by Qiu et al. pooled six prospective accelerometer cohorts, covering 13,960 people. Each additional 30 minutes per day of LPA was associated with a 20% lower risk of cardiovascular mortality (hazard ratio 0.80; 95% CI, 0.67 to 0.96). The dose-response curve was nonlinear: early increases appeared to provide more benefit, with a plateau at higher volumes.

Its substitution analysis pointed in the same direction. Replacing 30 minutes per day of sedentary time with LPA was associated with 16% lower cardiovascular mortality (HR 0.84; 95% CI, 0.73 to 0.96). When the analysis matched LPA and moderate-to-vigorous activity by time, moderate-to-vigorous activity performed better. When it matched them by energy expenditure—150 MET-minutes per day—the estimates did not differ significantly (HR 0.67 versus 0.54; P for comparison=0.41).

That comparison supports a sensible interpretation: light movement can contribute meaningfully, but it usually takes more of it to deliver the same energy expenditure as harder work. It does not prove that light activity and vigorous activity have identical biology.

Different cohorts find a similar direction, with different answers to the harder question

Several cohorts link more LPA with lower mortality. In a 10-year Japanese study of 1,723 community-dwelling adults aged 65 and older, higher accelerometer-measured LPA was associated with lower all-cause mortality. The result remained materially unchanged after researchers excluded deaths in the first five years, which reduces—but does not eliminate—the concern that illness caused both inactivity and early death.

A French study of 1,011 retirees, all age 65 at baseline, followed participants for 18 years and found self-reported LPA was significant in spline-based models for all-cause mortality (P=0.0401) and cardiovascular mortality (P=0.0112). Moderate-to-vigorous activity showed stronger statistical associations in the same cohort. The PROOF cohort study adds useful long-term evidence, but its questionnaire cannot reliably distinguish light from moderate activity at the boundary.

The large Korean NHIS-Senior cohort, which included 58,537 adults age 65 and older, also reported dose-dependent associations between self-reported LPA and all-cause mortality. Its definition of "light" activity included slow or leisurely walking assigned 3.0 METs. That is at the threshold commonly used for moderate intensity in accelerometer classifications, so the result cannot cleanly answer what device-measured LPA alone does.

Why the studies do not justify treating light activity as a substitute for training

The strongest caveat comes from the same UK Biobank analysis that produced the VPA-to-MPA ratios. After mutual adjustment for VPA, MPA, sedentary time, and other activity intensities, LPA associations with cardiovascular mortality, major adverse cardiovascular events, and cancer mortality did not reach statistical significance. The study found only subtle gradients for all-cause mortality and type 2 diabetes. Its calculated LPA-to-VPA exchange ratios—53 to 156 minutes of LPA per minute of VPA, depending on outcome—therefore have limited practical meaning for outcomes where LPA itself was not statistically significant.

The Japanese study reached a similar caution by another route. Replacing sedentary time with moderate-to-vigorous activity significantly lowered all-cause mortality risk, while replacing it with LPA alone did not produce a statistically significant result. A 2024 study of British older adults also found that movement profiles dominated by LPA without substantial moderate-to-vigorous activity did not show the mortality protection seen in mixed, high-MVPA profiles.

These designs ask a more demanding question than whether active people live longer: does light movement itself predict better outcomes after accounting for the rest of a person's movement pattern? The answer depends on the endpoint and model. LPA may help partly because it displaces sitting, partly because it accompanies moderate activity, and partly because healthier people can move more. All three can be true at once.

Light activity is a credible way to reduce sedentary time. The evidence does not support using it as a full replacement for moderate or vigorous exercise when cardiovascular and cancer risk are the targets.

Wearables improve measurement, not certainty

Questionnaires capture planned exercise reasonably well but perform poorly for the slow walking, standing, errands, and household tasks that fill the LPA category. In a paired UK Biobank comparison, Bürki et al. found that self-reported and device-measured activity showed discordant associations with cardiometabolic risk. The instruments are not merely two rulers with different markings; they capture different behavior with different errors.

Accelerometers have errors of their own. Wrist devices can mistake arm motion for greater intensity, and the UK Biobank classifier was not independently validated specifically in adults 65 and older. The Japanese study used an algorithm developed in adults aged 20 to 59 years, with larger documented prediction errors in older adults. Most cohorts also measured activity once, then followed people for years; no baseline week can capture a decade of changing habits.

Nor can observational cohorts prove that assigning a sedentary person to a specific dose of LPA or VPA would produce the observed hazard ratios. UK Biobank participants also tend to be healthier, more educated, and less ethnically diverse than the broader UK population. The estimates are informative, but they are not a personalized forecast from your watch.

What to do with the evidence

Use the hierarchy the data support. First, reduce long stretches of sitting with movement you can repeat daily. Slow walks, standing tasks, and gentle chores are worth treating as real activity, especially for people with low exercise capacity. In people with prediabetes or diabetes, a prospective substitution study found that replacing sedentary time with any activity intensity was associated with lower mortality risk.

Then build moderate activity, because it has a stronger per-minute association with major outcomes than LPA. Add vigorous activity when it is safe, enjoyable, and appropriate for your fitness and medical context. The wearable evidence suggests that vigorous minutes deserve more credit than the old 2-for-1 conversion gives them.

The least defensible plan is to chase a step total while avoiding every sustained bout that raises your heart rate. The better plan is less sitting, plenty of accumulated movement, regular moderate work, and some vigorous work if you can do it safely. Wearables can measure that pattern far better than a memory-based questionnaire. They cannot make the causal uncertainty disappear.